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Asmuch as a quarter of the human genomehas been reported to vary in copy number between individuals, including regions containing
about half of the members of the olfactory receptor (OR) gene family. We have undertaken a detailed study of copy-number variation of
ORs to elucidate the selective andmechanistic forces acting on this gene family and the true impact of copy-number variation on human
OR repertoires. We argue that the properties of copy-number variants (CNVs) and other sets of large genomic regions violate the assump-
tions of statistical methods that are commonly used in the assessment of gene enrichment. Usingmore appropriate methods, we provide
evidence that OR enrichment in CNVs is not due to positive selection but is because of OR preponderance in segmentally duplicated
regions, which are known to be frequently copy-number variable, and because purifying selection against CNVs is lower in OR-contain-
ing regions than in regions containing essential genes. We also combine multiplex ligation-dependent probe ampliﬁcation (MLPA) and
PCR to assay the copy numbers of 37 candidate CNVORs in a panel of ~50 human individuals. We conﬁrm copy-number variation of 18
ORs but ﬁnd no variation in this human-diversity panel for 16 other ORs, highlighting the caveat that reported intervals often overre-
present true CNVs. The copy-number variation we describe is likely to underpin signiﬁcant variation in olfactory abilities among human
individuals. Finally, we show that both homology-based and homology-independent processes have played a recent role in remodeling
the OR family.Introduction
A ﬁrst step in the perception of smells is recognition of
odorants by olfactory receptors, or odorant receptors
(ORs). ORs are seven-transmembrane G protein-coupled
receptors that are expressed in the nasal olfactory epithe-
lium.1 ORs comprise one of the largest gene families in
mammalian genomes, with ~400 apparently functional
members in the human genome2,3 and ~1200 apparently
functional members in mice.4,5 An exquisite yet mysteri-
ous transcriptional regulatory regime ensures that each
neuron in the olfactory epithelium expresses only a single
allele of a single member of the OR gene family.6–8 The
axons of neurons that have chosen to express the same
OR gene converge in the olfactory bulb of the brain,9
thus allowing integration of signals elicited in functionally
identical neurons and highly sensitive odorant detection.
It has been difﬁcult to comprehensively determine the
odorant ligands that activate each OR, but from initial
studies, it is clear that a combinatorial code operates,
whereby one receptor type can respond to several different
odorant molecules (perhaps with varying afﬁnities) and
a single odorous compound can be recognized by a number
of different receptor types.8 This combinatorial coding re-
gime allows the detection and discrimination of far more
odorant molecules than the number of distinct receptors
in the genome, explaining how humans can detect thou-
sands of odorants despite possessing only ~400 distinct
functional OR genes. In this study, we investigate human
genotypic variation in functional OR repertoire size. Thisvariation could explain some of the observed phenotypic
variation in our sense of smell.
In addition to containing apparently functional ORs, the
gene family also contains many members that have
acquired inactivating mutations, rendering them pseudo-
genes.2 The proportion of the OR family that appears func-
tional differs greatly among species, with about 50% in
human and chimp,10 70% in rat,11 and 80% in mouse and
dog.5,12 The proportion of intact ORs is also known to
vary between human individuals, because at least 26 OR
genes are known ‘‘segregating pseudogenes,’’ containing
single-nucleotide polymorphisms (SNPs) in which one
allele encodes an apparently functional product and the
other encodes a pseudogene.13 The relatively low propor-
tion of intact genes among human ORs and those of other
primates as compared to rodents and dogs suggests that se-
lective pressure to maintain a large functional repertoire is
less strong in primates than in dogs and rodents. Several
investigators have speculated that acquisition of trichro-
matic vision contributed to the declining importance of
olfaction in primate ecology.14–16 Here, we examine the
selective pressures acting on copy-number variation in the
human OR repertoire.
Mammalian OR genes are arranged in a number of geno-
mic clusters that arose via numerous tandem duplications,
as well as less frequent interchromosomal duplications,
that seeded new clusters.2,5 The human genome contains
~100 OR clusters, containing between one and 105 genes.
Some human ORs have multiplied to relatively high copy
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(SDs) in the human genome,17 including several ORs in
subtelomeric regions18 and pericentromeric regions,5 as
well as a large number of members of the 7E subfamily of
OR pseudogenes.2,19 Comparative genomic analyses of
mammalian OR repertoires show that duplications and
deletions that occurred after the divergence of various
lineages explain the varying repertoire sizes of different
species,3,5,20 a mode of evolution known as birth-and-
death evolution.21
Each genetic difference between species initially arose
in the genome of a single individual and went through a
period of polymorphism before becoming ﬁxed in the
population, either by genetic drift or through the action
of selection.22 It is therefore likely that the same duplica-
tion and deletion processes that have altered the OR family
over the course of mammalian evolution are still at work
today, resulting in OR repertoires that vary between mem-
bers of a single species, with the likely phenotypic conse-
quence of interindividual variation in olfactory abilities.
Indeed, we previously showed that several subtelomeric
ORs are polymorphic in both copy number and genomic
location in the human population.18,23 Furthermore, nu-
merous studies that report copy-number-variable regions
in the human genome includemany intervals that contain
OR genes (e.g.,24–26). Some studies report that genes
involved in chemosensory perception are statistically sig-
niﬁcantly enriched in copy-number variant (CNV) re-
gions.26–28 These whole-genome studies used microarray
technology, SNP data, and high-throughput sequencing
methods to identify thousands of regions, spread through-
out the human genome, that contain deletions or duplica-
tions of several kilobases of DNA sequence in some individ-
uals but not in others; these polymorphisms are known as
copy-number variants.
We undertook a detailed study of OR-containing candi-
date CNVs in order to answer the following questions:
Does OR enrichment in CNVs remain statistically signiﬁ-
cant after genomic clustering of ORs is accounted for? Is
OR enrichment in CNVs merely a consequence of the
fact that about a quarter of ORs reside in segmental du-
plications, regions that are themselves enriched in
CNVs?29,30 Can copy-number-variation data provide evi-
dence for selective pressures on OR genes? Are ORs that
are reported in candidate CNVs in genome-wide studies
truly variable in copy number? Do reported OR-containing
CNVs represent genomic deletions or duplications? What
is the true range of functional OR repertoire size in the hu-
man population? And, lastly, what is themechanism of the
mutational events that result in OR copy-number
variation?
Material and Methods
CNV, Segmental Duplication, OR and V1R Data Sets
We obtained a set of 29,107 candidate copy-number-variable re-
gions (CNVRs) (after excluding inversions) and their coordinatesThe Amein NCBI’s Build 36.1 of the human genome assembly from the
Database of Genomic Variants (The Centre for Applied Genomics,
The Hospital for Sick Children, University of Toronto, updated
Nov. 29th, 2007).31 Many variants in this data set overlap one
another, so we condensed the data set to a nonredundant collec-
tion of 15,376 candidate CNVRs with custom perl scripts. Segmen-
tal-duplication coordinates17 were obtained through the UCSC
Genome Browser.
We identiﬁed the coordinates of OR and vomeronasal receptor
family 1 (V1R) genes in the human genome assembly (NCBI Build
36.1) or in alternative genomic-sequence sources with the use of
previously described procedures.5,32 Our previous V1R study in-
volved manual elimination of sequences that matched V1Rs
very poorly; we modiﬁed the procedure to allow automated elim-
ination of such sequences. Our modiﬁcations consisted of (1) us-
ing RepeatMasker with default settings (in addition to our usual
run with the –nolow setting) and eliminating candidate V1Rs
that fall entirely within a repeat and (2) eliminating any candidate
V1R without a BLAST match of E > 105 in the NR protein data-
base. The remaining 116 candidate V1Rs had a BLAST match of
at least E ¼ 105 that contained either ‘‘pheromone,’’ ‘‘vomero-
nasal,’’ or ‘‘V1R’’ in the description, implying that ﬁltering was
successful. An acedb database was used to help track relationships
between OR and V1R genes and CNVRs.33
We also determined the ofﬁcially approved ‘‘HORDE’’ names for
each of the identiﬁed OR genes by performing a BLAST search of
each sequence to the HORDE database (kindly supplied in fasta
format by Tsviya Olender, Weizmann Institute). In ambiguous
cases in which more than one HORDE gene was identical to an
OR that we found, we matched genomic coordinates to choose
the correct gene name. In some cases, our assignment of a gene
as intact or disrupted (pseudogene) disagreed with the HORDE as-
signment—analysis of these cases is provided in Table S1 (available
online). One such case,OR56B2, is one of the genes we found to be
copy-number polymorphic. HORDE assigns this gene as a pseudo-
gene because it is missing a start codon in the typical place; we as-
sign this gene as intact because it is known that some ORs encode
the start codon in an upstream exon,23 so that lack of a start codon
in the main exon might not be sufﬁcient to call a gene disrupted.
We therefore refer to this gene asOR56B2, rather than asOR56B2P.
Two V1R genes previously described as intact appear to be pseudo-
genes in the reference assembly, as discussed in detail elsewhere.32
Simulation Studies
In order to determine the approximate statistical signiﬁcance of
OR enrichment in CNVRs and the number of ORs expected in
CNVRs by chance (Table 1), we simulated 5000 data sets of geno-
mic regions with the same characteristics as the real CNVR data
set. A single simulated data set was generated as follows, and the
entire process was repeated 5000 times. First, we sorted the sizes
of the real CNVRs in descending order. We then imagined an arti-
ﬁcial genome, consisting of one copy of each chromosome, in an
order that we shufﬂed randomly before generating each of the
5000 simulated data sets. Each chromosome’s length reﬂects its
length in the Build 36.1 genome assembly. A single imaginary,
linear genome was formed by joining of all chromosomes laid
end-to-end. A large number of possible start positions were picked
randomly within that single imaginary genome, with the use of
the runif function of R to sample from a uniform distribution,
rounding positions to the nearest base pair. Next, we paired a ran-
domly chosen start position with the size of the largest real regionrican Journal of Human Genetics 83, 228–242, August 8, 2008 229
Table 1. ORs and V1Rs Are Statistically Significantly Enriched in CNVRs
No. of Genes
in CNVRsa
Mean no. of Genes
in Simulated
CNVR Sets
Gene
Enrichmentb
No. of CNVRs
Containing
Genes
Mean no. of CNVRs
Containing Genes
in Simulated Sets
CNVR
Enrichmentb p Valuec
all ORs 140 (16%) 28 5.003 24 6 4.213 < 0.0002
intact ORs 62 (15%) 13 4.673 13 3 4.113 < 0.0002
OR pseudogenes 78 (17%) 15 5.303 20 5 4.193 < 0.0002
ORs in SDs 77 (36%) 7 11.083 19 3 6.713 < 0.0002
ORs outside SDs 63 (10%) 21 2.993 10 4 2.693 0.0040
Intact ORs outside SDs 40 (12%) 11 3.593 8 3 3.053 0.0044
OR pseudogenes outside SDs 23 (8%) 10 2.323 9 3 3.013 0.0034
V1Rs 23 (20%) 4 6.263 10 2 4.603 < 0.0002
V1Rs in SDs 14 (29%) 2 8.843 7 1 6.753 < 0.0002
V1Rs outside SDs 9 (14%) 2 4.303 6 1 4.383 0.0022
a Number of genes overlapping CNVRs in a data set comprising 453 regions reported by Redon et al.28 in more than one individual, ascertained with high-
resolution arrays.
b Enrichment levels reflect how many more genes were in CNVRs (or how many more CNVRs contained genes) in the real data set than occurred in the mean
of 5000 simulations.
c p values reflect the proportion of simulations in which at least as many CNVRs contained genes as were observed in the real data.and generated start and end coordinates of that simulated region
within the single linear genome. If the simulated region spanned
one or more boundaries between chromosomes in the artiﬁcial
single genome, we converted the coordinates of the region to
two or more smaller regions that together span the same parts of
the artiﬁcial genome as the larger region, split at chromosome
boundaries (a possible alternative strategy of rejecting regions
spanning more than one chromosome would bias simulated
regions away from chromosome ends). We continued by pairing
another randomly chosen start position with the size of the
next-largest real region. If that simulated region overlapped by
any amount with any region(s) previously simulated, new start po-
sition(s) were selected until a region was generated that did not
overlap with any previously chosen region. We continued until
we had simulated nonoverlapping regions corresponding to all
real-region sizes and thus had produced a data set of simulated
regions with the same characteristics as our real data set in terms
of size distribution and total nonoverlapping genomic extent
covered.
Sequence Analysis
To identify possible additional OR-containing candidate CNVs, we
performed bioinformatic analyses, as outlined in the text. We used
each of the 4121 OR sequences identiﬁed from alternative geno-
mic-sequence sources as BLAST queries against the set of ORs
that we identiﬁed from the Build 36.1 reference genome assembly,
and we performed simple ﬁltering of BLAST results to determine
that 47 of the alternative-source ORs did not have a match of at
least 98% nucleotide identity over at least 95% of the length of
the shorter of the two matching sequences and were thus candi-
date copy-number-variable ORs. Manual inspection revealed that
11 of the ‘‘nonmatching’’ ORs were likely to be derived from
poor quality sequence, given that they mapped close to a gap be-
tween contigs in the BAC sequence. Another 11 nonmatchingORs
had a good match with overall identity percentage below 98%
(e.g., the alignment included a single < 50 bp insertion/deletion
difference)—these were eliminated from further analysis. At this
point, multiple computational tools were used for comparing ge-230 The American Journal of Human Genetics 83, 228–242, Augustnomic sequences surrounding the candidate variable ORs to iden-
tify possible alternative structural alleles and to examine their
breakpoints. These tools included Dotter,34 BLASTZ,35 BLAST,36
CLUSTAL W,37 cross_match, RepeatMasker, and BOXSHADE. For
one OR, we found that the absence of a BLAST match was merely
due to unusually high sequence divergence of the ORs and did not
appear to represent an alternative structural allele. Although this
case might represent a set of interesting sequence polymorphisms,
it is outside the scope of this study. The remaining nonmatching
ORs represent candidate copy-number-variable genes and are
further discussed in the text and detailed in Table 2 and Tables
S3 and S4.
DNA Samples
We obtained human BAC CTD1-2361F20 from BAC/PAC Re-
sources (CHORI). Human genomic DNA was puriﬁed from lym-
phoblast cell cultures, obtained from the NIGMS Coriell Cell
Repositories (Camden, NJ) or purchased as DNA from the same
source. Samples were from 52 individuals of various geographic or-
igins: eight African Pygmies, including three Mbuti (GM10492-4)
and ﬁve Biaka (GM10469-73); ﬁve Middle Eastern Druze
(GM11521-5); nine Southeast Asians, including ﬁve Melanesians
(GM10539-43) and four Cambodians (GM11373, GM11375-7);
ﬁve South American Indians (Karitiana, GM10965-9); four Central
American Indians (Mayan, GM10975-6, GM10978-9); ten African-
Americans (GM10731-40); and eleven individuals of European an-
cestry (GM00893, GM00946, GM01310, GM01805-6, GM01814,
GM01953, GM08428, GM09948, GM10534, GM14492).
MLPA Assays and Interpretation
Multiplex ligation-dependent probe ampliﬁcation (MLPA)38 was
performedwith the use of customprobes (Table S5) withMRCHol-
land’s EK1 kit, according to the manufacturer’s ‘‘DNA Detection/
Quantiﬁcation’’ protocol. We were careful not to include known
SNPs near the ligation sites of our MLPA probes because these
can interfere with hybridization and ligation.38 Our probe mixes
consisted of 0.8 pmol of each half probe plus 7.8 ml SALSADQ con-
trol mix (MRC Holland), diluted to a total volume of 200 ml8, 2008
Table 2. Summary of Experimentally Validated CNVs and SNPs that Affect Functional Copy Number
OR(s) Affected
Chr.
Location Description of Alternative Structural Allelesa
Allele
Frequencies
Rearrangement
Mechanism
OR2G6 1q44 - Presumed ancestral, unduplicated (b36.1).
OR is in unique sequence flanked by a recent
inverted ~100 kb duplication
99% Not determined
- Presumed duplicated (MLPA) 1%
OR2T11 1q44 - Presumed ancestral, undeleted (b36.1). OR
in one arm of recent inverted ~100 kb
duplication (OR deleted from other arm)
91% Not determined
- Presumed deleted (MLPA) 9%
OR51A2 11p15.4 - Undeleted (b36.1) 72% NAHR within ORs
- 8.6 kb deletion (fosmid AC193108) removes
OR51A2 (also noted by Korbel et al.57)
28%
OR56B2, OR52N5, OR52N1 11p15.4 - Undeleted (b36.1) 79% NHEJ between
Alu repeat and
OR52N1
- 24.7 kb deletion (fosmid AC193144)
removes OR56B2, OR52N5, and half of
OR52N1
21%
OR52E8 11p15.4 - Undeleted structural allele (b36.1) also
exhibits SNPs that can inactivate OR52E8
(dbSNP: rs12419602 and ss99307947)
Intact 56%
Pseud. 37%
NHEJ
- 9.5 kb deletion (fosmid AC206475) removes
OR52E8
7%
OR4C45 11p11.2 - SNP: TAT 46% T/G SNP
- SNP: TAG stop codon (dbSNP: rs3898634) 54%
OR4C11, OR4P4, OR4S2,
OR4V1P, OR4P1P
11q11 - Undeleted (b36.1) 65% NHEJ, but see
text, Figure S1- Fosmids AC193142 and AC210900 contain
complex alternate structure, with four
deletions and some inversions (Figure S1)
35%
OR8U8, OR8U9, OR8U1 11q11 - Undeleted (Celera) 88% NAHR within ORs
- 7.6 kb deletion (b36.1) joins parts of OR8U8
and OR8U9, creating hybrid gene OR8U1
12%
OR9G9 11q11 - Undeleted (Celera) 99% NAHR outside ORs
- 11.1 kb deletion (b36.1) removes OR9G9 1%
OR8G1 11q24.2 - Undeleted (Celera) 55% NHEJ between
OR and unique
sequence
- 851 bp deletion (b36.1) near end of OR. SNP
on same haplotype also creates premature
stop (dbSNP: rs4268525)
45%
OR4K2 14q11.2 - Presumed ancestral, unduplicated 63% Not
determined- Presumed duplicated 37%
a b36.1 indicates reference human genome assembly, NCBI Build 36.1.with TE. Denaturation, hybridization, ligation, and PCR were
performed according to protocol, except that samples were placed
on ice while probe mix, MLPA buffer, ligation-buffer mix, and
polymerase mix (MRC Holland) were added. Completed MLPA re-
actions were diluted 1:11 in water, and 1 ml of each diluted product
was combined with 0.05 ml GeneScan 500 LIZ Size Standard and
10 ml Hi-Di formamide (Applied Biosystems). Products were sepa-
rated and quantiﬁed with the use of an ABI-3730 DNA Analyzer
with 2 kV injection voltage and 2 s injection time. GeneMapper
3.7 or 4.0 software (Applied Biosystems) was used to determine
peak heights and areas and fragment sizes in base pairs, with the
use of a peak window size of 11.
Custom perl and R scripts were used for processing of peak
heights, which we found to be a more reliable measure of copy
number than peak areas. For each sample we ran, the peak heightsThe Amefor OR probe pairs were normalized in order to enable interindivid-
ual comparisons by division of each peak height by the averaged
peak-height value for two control genes that should not vary in
copy number, EXT1 and EP300. We eliminated a small number
of samples for which large peaks (normalized height > 0.2) were
observed for any of three DNA quality-control probes provided
by MRC Holland (DQ64, DQ70, and DQ76)—when sample DNA
quality is high, peaks for these probes are either absent or very
small. After these steps, peak heights for each probe were com-
bined across the three replicates for each DNA sample and average
and standard-deviation values were calculated. A minority of
peaks whose coefﬁcient of variation between triplicate measure-
ments from a single individual (standard deviation / average)
exceeded 0.3 were considered unreliable, and the peak in that
individual was excluded from further analysis. The ﬁnal averagedrican Journal of Human Genetics 83, 228–242, August 8, 2008 231
values were then plotted and sorted by peak height to facilitate the
assessment of copy-number variation. If variation appeared to be
present, samples were manually grouped into individuals with
the same allelic state. We investigated the use of statistical
methods that could replace this manual analysis step, but we
found that with only ~50 samples and experimental noise, no sim-
ple, reliable method exists that could solve this problem. Peak
heights were then averaged for all individuals with the same allelic
state, and relative copy numbers were inferred by comparing these
averages.
Our assay included two probe pairs, each of which we deliber-
ately designed to recognize two almost-identical OR sequences
(i.e., in a ‘‘normal’’ diploid individual would recognize four cop-
ies), due to the difﬁculty of ﬁnding sequence differences that
would enable the design of speciﬁc probes. Our intentional use
of probes that recognize multiple ORs was not always effective.
In one case, a probe pair that recognizes OR51A2 and OR51A4,
we efﬁciently detected a polymorphic deletion (four copies versus
three or two). However, in the second case, a probe pair that recog-
nized both OR2A42 and OR2A1, results were ambiguous. No clear
grouping of samples into different copy numbers was evident, yet
the peak heights for this probe were much more variable among
individuals than for most invariant control and OR probe pairs
that we have surveyed (coefﬁcient of variation [CV] 0.19, whereas
most invariant probes have CV < 0.075). Polymorphic duplica-
tions are likely to be present for one or both of these genes, increas-
ing the number of gene copies that this probe pair would recog-
nize to 5, 6, or higher, but experimental noise (which can be
worse for some probe pairs than for others) makes it difﬁcult to
distinguish groups with different copy numbers when the initial
copy number is high (e.g., four copies compared to ﬁve would
result in a 1:1.25 peak-height ratio, which is more difﬁcult to de-
tect than two copies compared to three; a 1:1.5 ratio).
Interpretation of results for a second probe pair (OR13C2) was
also difﬁcult, although the sequence of the reference assembly
suggests that the MLPA probes should match only one genomic
location. Two samples appear to have lower peak heights than
those of the other samples, but the mean peak heights for the two
groups of samples do not have the proportions expected for a true
copy-number-variable gene (e.g., 1:2, 3:4, etc.). In addition, the
main groupof samples has a rather variable peakheight, suggesting
that results for this probe pair are subject to experimental noise.
PCR and Sequencing
PCR was performed with the use of standard protocols, with
Biolase DNA Polymerase and buffer (BIOLINE). Primer sequences
are given in Table S8. Annealing temperatures and detailed condi-
tions for each reaction will be provided on request. For DNA
sequencing, PCR products were puriﬁed with Sephacryl S-300
(Amersham Biosciences) and subjected to sequencing, with the
use of a custom primer (Table S8), Applied Biosystems’ BigDye Ter-
minator v3.1, and an ABI3730, according to the manufacturer’s
recommendations.
Results
Over 400 Human ORs are Reported to Be Variable
in Copy Number
We were intrigued by reports of the enrichment of OR
genes in regions of copy-number variation (e.g., 27,28).232 The American Journal of Human Genetics 83, 228–242, AugustTherefore, we obtained coordinates of 15,376 nonoverlap-
ping candidate CNVRs from the Database of Genomic Var-
iants, a collation of data from 46 publications (The Centre
for Applied Genomics, The Hospital for Sick Children, Uni-
versity of Toronto).31 Note that each region in the database
may represent several overlapping CNVs found in one or
more studies—here, we use the abbreviations CNVR
(copy-number-variable region), to denote an interval con-
taining one or more variants, and CNV (copy-number var-
iant), to denote a particular segregating variant. Together,
the 15,376 CNVRs span a total of 810Mbp, ~25% of the ge-
nome. We also used our bioinformatics tools to locate all
896 OR genes and pseudogenes in the same version of
the genome assembly (NCBI Build 36.1). We eliminated
44 ORs derived from redundant sequence (the assembly
contains three alternate haplotype sequences for the major
histocompatibility complex region) or whose chromo-
somal assignment is not precisely known (e.g., chr8_ran-
dom). There remained 852 mapped ORs, of which 405
(48%) appear to be intact and 447 (52%) are pseudogenes
(Table S1).
Comparing the coordinates of the ORs and candidate
CNVRs, we found that 429 of the 852 (50.4%) human
ORs overlap 68 candidate CNVRs, a remarkably high pro-
portion. However, our experimental studies indicate that
not all of these ORs truly vary in copy number, which
probably reﬂects both reported CNVR boundaries that
overestimate the truly variable region and false-positive
CNVRs (see below). Therefore, we restricted our computa-
tional analyses of copy-number variation to a subset of
more reliable regions whose boundaries are deﬁned at
higher resolution. The Database of Genomic Variants31
contains 453 CNVRs, deﬁned by Redon et al.28 with the
use of high-resolution arrays (‘‘500K EA’’) that showed
copy-number gain or loss in at least two individuals sam-
pled and, thus, are less likely to represent false-positive
CNVRs. These 453 CNVRs comprise 102 Mbp (~3% of
the genome) and overlap 140 (16.4%) of the 852 mapped
ORs (Table 1), still a very signiﬁcant proportion of the
gene family. Similar fractions of intact ORs (62/405,
15.3%) and OR pseudogenes (78/447, 17.5%) appear to
be in CNVRs.
Some studies have examined the statistical signiﬁcance
of the enrichment of ORs and other functional categories
of genes in CNVRs with the use of hypergeometric tests
(e.g., 27,28,39). We were concerned that the clustered geno-
mic arrangement of ORs (and other tandemly duplicated
gene families) can result in individual CNVRs affecting
multiple family members at once, resulting in a ‘‘jackpot’’
effect30 that invalidates the assumption, made by hyper-
geometric tests, that all members of a gene category behave
independently.40 Therefore, we used simulation studies
to assess the statistical signiﬁcance of the observed large
overlap between ORs and CNVRs (Table 1, Material and
Methods). Other investigators have used a similar ap-
proach to determine the signiﬁcance of some properties
of CNVR data sets, such as GC and repeat content.27 In8, 2008
brief, we simulated 5000 artiﬁcial CNVR data sets with the
same length distribution as the real CNVR data set and
determined the overlap between each simulated CNVR
set and the real OR coordinates. We used the mean overlap
found in simulations as a baseline for determining the fold
enrichment of ORs in the real CNVR data set and obtained
a p value for the observed data by determining the propor-
tion (if any) of simulated data sets with the same or higher
level of enrichment as that observed in the real data. We
ﬁnd that 4.21 times as many CNVRs contain ORs as would
be expected if CNVRs were distributed randomly in the
genome and that such enrichment is highly unlikely to
happen by chance (p < 0.0002).
OR Enrichment in CNVRs due to Segmental
Duplications and Diminished Purifying Selection,
Not Positive Selection
We sought to distinguish between alternative explanations
for the enrichment of ORs in CNVRs. One possible expla-
nation is that CNVs are not randomly distributed in the ge-
nome, as assumed by our simulations. CNVRs are known
to frequently coincide with regions of segmental duplica-
tion, perhaps because SDs are inherently unstable regions
of the genome.29,30 Furthermore, many ORs are found in
regions of segmental duplication, perhaps explaining their
enrichment in CNVRs. SDs are sequences duplicated in
more than one genomic location and can span as much
as several hundred kilobases.17 They are found in many
genomic locations, are enriched near telomeres and cen-
tromeres, and together make up ~5% of the human
genome.17 To determine the role of SDs in OR-CNVenrich-
ment, we separately analyzed the 213 ORs found in SDs
and the remaining 639 ORs. ORs in SDs indeed showed
a greater CNVR enrichment (6.71-fold more CNVRs than
expected contain SD ORs, p < 0.0002) than did other
ORs (Table 1). However, ORs outside of SD regions were
still signiﬁcantly enriched in CNVRs (2.69-fold more
CNVRs than expected contained these ORs, p ¼ 0.004).
These ﬁndings argue that the frequent presence of ORs in
SD regions is largely, but not solely, responsible for OR
enrichment in CNVRs.
A second possible explanation offered by some authors
(e.g., Nguyen et al.27) is that positive selective pressures
could favor copy-number variation in ORs if changes in
the OR repertoire provide enhanced olfactory capabilities
and are thus selected for as humans adapt to new environ-
ments (and new odors). If positive selection operates, we
would expect intact ORs to be more highly enriched in
CNVRs than are OR pseudogenes, given that variation in
intact ORs could have phenotypic consequences that
selection might act upon whereas variation in OR pseudo-
genes could not. However, the similarity in CNVR-enrich-
ment levels between intact ORs and OR pseudogenes
(15.3% versus 17.5%, Table 1) indicates that positive selec-
tion has not driven OR CNVR enrichment. This compari-
son between intact ORs and pseudogenes oversimpliﬁes
a complex issue: because intact ORs and pseudogenes areThe Ameinterspersed with one another, most CNVs affect several
genes, including ORs of both categories, and it is therefore
not possible to distinguish which OR(s) within the CNV
might have been the target of presumptive selection. It
remains possible that OR-containing CNVs rose to high
frequency due to positive selection on the intact genes
within them, carrying along neighboring pseudogenes by
a ‘‘hitchhiking’’ effect and resulting in approximately
equal rates of intact-OR and pseudogene enrichment in
CNVRs.We therefore looked for CNVRs that contain solely
intact ORs or solely OR pseudogenes. Although too few
CNVRs remain for statistical analyses, we ﬁnd that CNVRs
that contain only OR pseudogenes are more common than
those that contain only intact ORs (data not shown), sup-
porting our conclusion that it is quite possible for OR-con-
taining CNVs to accumulate in the absence of positive
selection.
We also examined the CNVR enrichment of the 116-
member human V1R vomeronasal receptor gene family
(Table S2). Like ORs, V1Rs also have a clustered genomic ar-
rangement and are often found in SD regions. Unlike ORs,
the V1R family consists almost entirely of pseudogenes32
and so can serve as a neutrally evolving ‘‘negative control’’
gene family. The vomeronasal system appears to have been
dysfunctional since before the ape and Old-World-monkey
lineages diverged;41 thus, it is very unlikely that selection
acts to favor or repress human CNVs that include V1Rs.
The enrichment of V1Rs in CNVRs is at least as high as
that for ORs (4.60-fold more CNVRs contain V1Rs than ex-
pected, p < 0.0002, Table 1), despite the impossibility of
positive selection favoring V1R-containing human CNVs.
The fact that such high levels of enrichment in CNVRs
are observed for a neutrally evolving gene family demon-
strates that CNVR enrichment alone cannot be taken as
an argument for positive selection being involved in that
enrichment. We conclude that the observed enrichment
of ORs and V1Rs in CNVRs probably reﬂects a combination
of (a) their frequent presence in SDs (see above) and (b)
a depletion of CNVs in other regions of the genome as a re-
sult of purifying selection against copy-number change of
dosage-sensitive genes, rather than the result of selection
having favored OR- or V1R-containing CNVs. Moreover,
our analyses hint that OR-containing CNVs might be
weakly selected against, given that CNVRs show a slightly
higher level of V1R enrichment (which presumably reﬂects
the rate of neutral CNV accumulation) than of OR enrich-
ment (4.383 versus 2.693, considering only the subsets of
genes outside SDs). However, differences in gene-family
size and genomic organization make it difﬁcult to test
the statistical signiﬁcance of the difference in CNVR
enrichment between classes of genes.
Bioinformatic Methods Provide Genomic Structures
for 16 Candidate OR-Containing CNVs
We identiﬁed pairs of genomic sequences representing the
two alleles of 16 candidate CNVs containing a total of 28
ORs (Table 2 includes the CNVs that we have conﬁrmedrican Journal of Human Genetics 83, 228–242, August 8, 2008 233
experimentally, and Tables S3 and S4 list all pairs of geno-
mic sequences discussed here). Such analysis allows design
of speciﬁc experimental assays for each allele and inference
of the mutational mechanisms that gave rise to copy-num-
ber variation. Sequences of alternative alleles were already
available for threeOR-containing candidateCNVs.42We in-
cluded two of these CNVs in our studies (OR8G1, OR8U8/
OR8U9/OR8U1), but we excluded the third because it
maps close to an assembly gap in a complex, highly dupli-
cated pericentromeric region of chromosome 22 and,
thus, might reﬂect assembly problems rather than true
structural variation. We identiﬁed 14 additional pairs of al-
ternative structural-allele sequences by comparing human
genomic sequences from various sources, comprising the
reference human genome assembly,43 BAC sequences
from the HTGS/NR division of GenBank (excluding ‘‘low-
pass’’ sequences), the Celera44 and Venter assemblies,45
and a number of human fosmids, many of which were se-
quenced because they were deemed likely to represent
structural variants25,46–48 (Washington University and
Broad Genome Centers, unpublished). We searched for
OR sequences identiﬁed from the alternative sources that
appeared absent in the reference assembly, reasoning that
if the reference assembly is indeed complete, the missing
ORs probably reveal sites where the reference assembly rep-
resents the deletion allele of a segregating polymorphism.
We compared the genomic sequences surrounding appar-
ently missing ORs to the corresponding region of the refer-
ence assembly todistinguish true candidateCNVs fromORs
that were actually present in both sources but with unusu-
ally high sequence divergence. Because these ‘‘alternative’’
sources do not represent complete assemblies, we did not
perform a reciprocal analysis of reference-assembly ORs
that appear to be absent from the alternative sets. In addi-
tion to performing this analysis driven by OR-coding re-
gions, we compared the structure of the reference genome
sequence with 26 fully sequenced fosmids to detect addi-
tional candidate CNVs. Each fosmid either contains at least
oneORgene or overlaps anOR-containing region of the ref-
erence genome assembly (Table S3).
Together, these bioinformatic analyses identiﬁed geno-
mic sequences of alternative structural alleles for 16 candi-
dateCNVs (several viamore thanone sequence source) con-
taining 12 intact ORs and 16 OR pseudogenes (Table 2,
Tables S3 and S4). These sequences allowed us to design
PCR-based assays to seven of the eight candidate CNVs
that contained intact ORs. We had already surveyed the re-
maining candidate CNV by MLPA. Together, these experi-
ments show that seven of the eight candidate CNVs are
truly variable in the population, whereas one represents
an artifact of the genome assembly (see below). Sequence
analyses of the alternative structural alleles revealed that
one particularly interesting CNV arose from a genomic de-
letion that was both destructive and creative: parts of two
ancestral ORs, OR8U8 and OR8U9, were joined to create
a novel intact hybrid OR, OR8U1, while eliminating the
ancestral genes.234 The American Journal of Human Genetics 83, 228–242, AugustMLPA Conﬁrms Seven Candidate Copy-Number-
Variable ORs and Fails to Conﬁrm 13 Others
Whole-genome methods provide evidence that over half
of the OR repertoire might be variable in copy number.
Even if CNVs containing ORs are not under strong positive
selection, as our simulation studies suggest, they could still
have interesting functional consequences on our olfactory
abilities. In order to understand the functional conse-
quences of this variation, we must ﬁrst conﬁrm bioinfor-
matic CNV predictions and array-based candidate CNVs
and accurately determine their genomic coordinates and
allele frequencies. Therefore, we developed MLPA- and
PCR-based assays to survey the copy number of a total of
37 ORs (33 intact ORs and four pseudogenes) and applied
those assays to DNA samples from ~50 human individuals.
Our DNA panel includes groups of individuals from diverse
geographic locations in order to allow the detection of
population-speciﬁc common variants as well as variants
found in multiple populations. Note that this approach
means that variants that are rare and population restricted
might be missed because the number of individuals
surveyed in each population is small.
MLPA38 is a method that can simultaneously assay the
copy number of at least 20 genomic regions relative to con-
trol regions that do not vary in copy number (Material and
Methods). As proof of principle, we used MLPA to assay an
X chromosome sequence on DNA from cell lines contain-
ing one, two, three, four, and ﬁve X chromosomes. We
found that peak height and area correlate well with X chro-
mosome copy number and that copy numbers between
1 and 5 can be readily distinguished by MLPA (data not
shown). To date, we have used 25 MLPA probe pairs (Table
S5) to assay the copy number of 24 ORs in a panel of ~50
human individuals, with each individual sampled in tripli-
cate. Two probe pairs simultaneously assay both members
of pairs of recently duplicated ORs, OR51A2/OR51A4 and
OR2A1/OR2A42, with the assay readout reﬂecting copy
number summed over both pair members (Material and
Methods). We ﬁnd that eight probe pairs in our panel ap-
pear variable in copy number (OR2G6, OR2T11, OR4C11,
OR4K2, OR8U8, OR51A2/OR51A4, and two probe pairs
for OR56B2), 15 probe pairs appear invariant (see below),
and results for two probe pairs cannot be interpreted
unambiguously (OR13C2 and the OR2A1/OR2A42 probe
pair) (Figures 1 and 2, Table 2, Table S6, Material and
Methods). PCR experiments conﬁrmed additional candi-
date CNVs (see below). Follow-up bioinformatic analyses
and PCR experiments showed that several of these con-
ﬁrmed CNVs contain one or more other ORs in addition
to the gene that was initially assayed (Table 2). Inferring
copy numbers from MLPA peak heights, we found four
polymorphic deletions (relative to the ancestral diploid
state, as determined by comparison to chimpanzee and
macaque assemblies49,50), two polymorphic duplications,
and another more complex case (OR2T11) in which a rela-
tively common deletion allele is present, as well as one
individual whomay carry a duplication (Table S7).We treat8, 2008
Figure 1. Copy-Number Assessment of Three Representative ORs by MLPA
Normalized peak heights (means of triplicate measurements) are shown for three MLPA probe pairs, each surveyed in 46 individuals. Peak
heights are proportional to genomic copy number. For each probe pair, samples are sorted in ascending order of peak height. Numbers in
gray represent mean peak heights for each group of samples with the same allelic state, with standard deviations for each group in
parentheses and inferred copy number given as, for example, CN2 (copy number ¼ 2).
(A) The OR8U8 probe pair reveals a polymorphic deletion. (B) The OR4K2 probe pair reveals a polymorphic duplication. Note that the ratio
of the mean peak heights of the genotype groups we have assigned is 2: 3.0: 4.0: 5.9. We treat the copy-number assignment of the in-
dividual who appears to have 6 copies tentatively at present, as well as two other allelic states only observed in a single individual in our
panel (three copies of OR2G6, three copies of OR2T11). Sampling a much larger panel of individuals, and/or DNA extracted independently
from the individual in question (not derived from an immortalized cell line) would be needed to increase confidence in these observa-
tions. (C) The OR6C1 probe pair does not reveal any copy-number variation, showing very consistent peak height across the panel of 46
individuals we surveyed.this ﬁnding of a multi-allelic CNV tentatively, as well as
two other structural alleles suggested by only a single indi-
vidual in our panel (the possibly multi-allelic OR4K2 [Fig-
ure 1] and the duplicated allele ofOR2G6). Assaying a larger
panel of individuals and/or independently extracted DNA
samples from the individuals concerned could determine
whether these structural alleles are valid or merely a spo-
radic artifact of MLPA or of immortalized cell lines.
Thirteen ORs appear invariant by MLPA yet lie within
putative CNVRs according to the Database of Genomic
Variants (OR2A14, OR2Y1, OR2Z1, OR4L1, OR5F1,
OR6C1, OR10AD1, OR11L1, OR52B4, OR52E2, and
OR52E5; as well as OR2F2 and OR5D18, which were each
assayed by two independent probe pairs). These ORs could
be in real CNVs with very rare minor alleles (< 1%), could
vary only in speciﬁc human populations not surveyed
here, or could be truly invariant in copy number. Because
many previously described CNVRs were deﬁned by
whole-genome surveys of limited resolution, e.g., compar-
ative genomic hybridization on BAC arrays, the regions
that are truly variable could be much smaller than the co-
ordinates reported. Our results are consistent with sugges-
tions by others30,47,51,52 that the true proportion of the
human genome that varies in copy number is lower than
the ~25% reported and show that fewer genes are variable
in copy number than CNVR databases suggest. A large, un-
biased screen for OR copy-number variation would be
needed to predict the proportion of the ~200 intact ORs
in candidate CNVRs that are truly variable. Because of
these caveats of published CNVR data sets, our statistical
analyses of gene enrichment in CNVRs (see above) usedThe Ameonly a higher-resolution, higher-conﬁdence subset of
CNVRs. The reduced data set contains 12 of the 15 ORs
that we showed to be truly CNV by MLPA and/or PCR but
only four of the 13 ORs that we did not ﬁnd to vary in
copy number. These numbers demonstrate that the reduced
set is greatly enriched for true copy-number variation as
compared to the unﬁltered data set of all 15,376 CNVRs.
PCR Experiments Conﬁrm Six Candidate CNVs and
Reveal an Artefactual Deletion in the Reference
Genome Assembly
With the sequence of alternative structural alleles in hand
from our bioinformatic analyses, it is relatively straight-
forward to design PCR assays to detect each allele and infer
the copy number of ORs in the region. We were able to
conﬁrm and determine the allele frequency for six CNVs
containing 14 ORs, including some of those that we had
assayed by MLPA (Table 2, Table S6). Together, these
PCRs and our MLPA analyses show that at least 16 intact
ORs and two OR pseudogenes vary in copy number.
Our PCR experiments also show that one of the
candidate CNVs that we predicted bioinformatically is
an artefact, representing a false ~62.4 kb deletion at
chr11:49995935 in the reference genome. This sequence
is at chr11:50190615–50253011 in the Celera assembly
and is also present in the Venter and chimpanzee assem-
blies and in the sequence of human BAC CTD1-2361F20.
It encompasses three ORs, OR4C49P, OR4C45, and
OR4C48P. We designed PCR assays speciﬁc to each putative
allele and found that no DNA sample could be ampliﬁed
with primers for the deleted allele. All 51 human DNArican Journal of Human Genetics 83, 228–242, August 8, 2008 235
Figure 2. Number of Functional Copies of 19 OR Genes Examined in a Panel of 51 Individuals
We summarize in this figure both copy-number variation and single-nucleotide polymorphisms that would disrupt OR function (‘‘segre-
gating pseudogenes’’), in some cases in the same gene. Figure S2 shows copy-number variation alone. Each row represents one of the
human individuals tested as part of our diversity panel. Each column of the grid summarizes genotype data for an OR gene or, in three
cases (*), for groups of OR genes (see below). Table 2 details the polymorphisms summarized in this figure. Genes are ordered according to
the number of copies gained or lost, averaged over the individuals surveyed. Full genotype data are also given in Table S7.
* ‘‘OR8U8,etc’’: a deletion CNV destroys function of OR8U8 and OR8U9, while simultaneously creating a novel hybrid gene, OR8U1;
‘‘OR56B2, etc’’: a deletion removes all of OR56B2 and OR52N5 as well as half of OR52N1; and ‘‘OR4C11, etc’’: a complex set of deletions
removes OR4C11, OR4P4, OR4S2, OR4V1P and OR4P1P (Figure S1).samples tested were positive for the undeleted allele, as was
DNA obtained from BAC RP11-1276E07, which was used
to construct the genome assembly. Thus, the BAC’s se-
quence (accession number AP006622) is erroneously miss-
ing this ~62 kb region, even though it is present in our iso-
late of the clone.
During our PCR, sequencing, and bioinformatic analy-
sis of candidate copy-number-variable ORs, we fortu-
itously noted and genotyped four single-nucleotide
polymorphisms (SNPs) in which the derived alleles dis-
rupt function of an OR, resulting in three ‘‘segregating
pseudogenes’’13 (OR52E8 and OR4C45, neither of which
was previously known to be a segregating pseudogene,
as well as OR8G1; Table 2) that could have functional con-
sequences.53 Function of OR52E8 and OR8G1 can be lost
in at least two ways, given that they both exhibit inacti-
vating SNPs and are contained within polymorphic geno-
mic deletions.
The minor-allele frequencies that we measured for OR-
containing CNVs range from 1% (the lower limit of our de-
tection ability in ~50 individuals) to 45%. For all CNVs, the
allele that we infer to be ancestral (based on comparative
analysis of chimpanzee assembly and, in one case, the ma-
caque assembly as well) is more common than the derived236 The American Journal of Human Genetics 83, 228–242, Augustallele among the individuals we surveyed. However, for
one SNP, the derived allele has risen in frequency to 54%.
Most CNVs that we surveyed were variant across several
of the geographically diverse subpopulations that we sam-
pled. This observation indicates an ancient origin, before
humans migrated out of Africa, and/or recurrent deletions
and duplications resulting in copy-number variation of the
same OR inmultiple subpopulations. Large-scale studies of
geographically diverse populations also show that the ma-
jority of SNPs and CNVs are polymorphic in all popula-
tions studied.54 Genotypes of individuals from the same
population do not cluster with one another on the basis
of the relatively small number of CNVs we surveyed
(data not shown), because most variation is shared
between populations.
Functional copy-number variation is great in our human
DNA panel, especially when CNV and SNP data are com-
bined (Figure 2, Table S7). No individual has the number
of functional copies expected from the reference assembly,
and almost every individual in our panel has a unique
combination of functional losses and gains among the
ORs we surveyed. Summing up functional copy-number
change over all genes assayed, we ﬁnd that the individuals
we surveyed have between 1 and 12 functional ORs fewer8, 2008
Figure 3. Cartoons of Genomic Structures and Breakpoint-Sequence Alignments of Two Representative Sets of Alternative
Structural Alleles
(A) Nonallelic homologous recombination (NAHR) between duplicated ~10.7 kbp sequence blocks with 84% identity, of which 180 bp is
shown aligned here. NAHR appears to have mediated a deletion that removes OR9G9. The ‘‘crossover’’ occurred somewhere within the 36 bp
of identical sequence indicated as ‘‘NAHR region.’’
(B) Nonhomologous end joining (NHEJ) mediated a deletion of OR56B2, OR52N5, and half of OR52N1—two bases of microhomology are
indicated at the deletion breakpoint. In both (A) and (B), derived sequences spanning the deletion (middle rows) are shown aligned with
the two ancestral sequences (outer rows). White letters on a black background indicate identical sequence; black letters on a white back-
ground indicate mismatched bases; ‘‘-‘‘ symbols indicate alignment gaps.than would be expected from the reference genome assem-
bly and, therefore, that some individuals have a total of 11
more functional OR copies than others.
The OR Family is Reshaped by both Homology-Based
and Homology-Independent Processes
Our identiﬁcation of pairs of sequences representing alter-
native structural alleles also allows us to infer the muta-
tional mechanisms underlying OR copy-number change.
Genomic deletions and duplications are known to occur
by several mechanisms, including nonallelic homologous
recombination (NAHR), nonhomologous end joining
(NHEJ), retrotransposition, and expansion of tandem re-
peats.55 In most cases, it is possible to deduce the mecha-
nism of rearrangement by examination of sequences
around rearrangement breakpoints.56 Recent stud-
ies47,51,57 have shown that human CNVs have arisen by
all four of these mechanisms. Given the clustered genomic
arrangement of the OR family, with many tandemly re-
peated sets of highly homologous sequences, we wonderedThe Amwhether NAHR would be largely responsible for rearrange-
ments in OR-containing regions. However, comparing the
breakpoint sequences of the seven pairs of alternative
structural alleles that we experimentally veriﬁed, we found
that both NAHR and NHEJ play a role in CNV formation in
OR-containing regions. Four deletion alleles contain only
a few bases of homology (‘‘microhomology’’) at deletion
breakpoints and were thus formed by NHEJ, and three
other deletion alleles show long homologous stretches at
their breakpoints (~900 bp–10.6 kb of R 84% identity,
with 34–212 bp stretches of 100% identity at breakpoints)
and thus probably result from NAHR (Figure 3, Table 2). In
one complex case (OR4C11; see Table 2 and Figure S1), the
derived structural allele appears to have arisen from the
ancestral sequence by four separate, but closely spaced,
deletions and two inversion events. Breakpoint analyses
implicate NHEJ as the mechanism in all these events, but
the fact that the region containing the three deletions is
ﬂanked by two very similar inverted copies of an L1 repeat
unit suggests that incorrect pairing of these repeats mighterican Journal of Human Genetics 83, 228–242, August 8, 2008 237
have resulted in a loop structure, withinwhich the complex
deletions and inversions could have occurred (Figure S1).
Discussion
Whole-genome surveys show that as many as half of the
~850 OR genes in the human genome, a remarkable pro-
portion, could be polymorphic in copy number. Although
our experimental studies show that the truly variable frac-
tion of ORs is likely to be lower than half, we observe
signiﬁcant variation in OR repertoire size among the ~50
human individuals we assayed. We show that at least ten
regions, containing 16 intact OR genes and two OR pseu-
dogenes, are variable in copy number in the human popu-
lation (1–5 ORs per region, Table 2). Fourteen intact ORs
are deleted in some individuals and not in others, and
three intact ORs are duplicated in a subset of individuals
(for one OR, both deletion and duplication alleles appear
to be present in the population). The polymorphic dele-
tions and duplications that we describe represent the raw
material on which genetic drift and/or natural selection
can act to ﬁx gene duplications and gene losses. Such du-
plications and deletions have, over time, resulted in
a ‘‘birth-and-death’’ style of evolution in the OR gene fam-
ily.5,21 We also describe SNPs that disrupt the function of
three of the ORs that we surveyed. With our CNV and
SNP genotyping results combined, the summed functional
copy number of the ORs we surveyed varies between indi-
viduals by up to 11 ORs. A comprehensive analysis will no
doubt reveal even more CNV ORs. Although we have not
identiﬁed every CNV OR, our in-depth analyses provide
reliable and absolute quantiﬁcation of copy number at pre-
cise genomic locations, unlike more-comprehensive mi-
croarray studies that generally scan the genome at lower
resolution and provide only relative, approximate ideas
of copy number. Our in-depth study also allows us to infer
that both homology-based and nonhomologous processes
are remodeling OR regions.
Such genotypic variation in the OR family among hu-
man individuals could have a signiﬁcant impact on our ol-
factory abilities. Deletion of one or more entire ORs could,
in homozygous individuals, result in partial or total insen-
sitivity to certain odorants that would normally be recog-
nized by the missing OR(s). Reduction in the diversity of
expressed receptor types might also reduce the complexity
of the combinatorial code and hamper the ability to dis-
criminate similar odorants. Duplications and heterozygous
deletions would probably alter the number of olfactory ep-
ithelial neurons choosing to express the affected receptor,
and, thus, they might alter sensitivity to the odorants rec-
ognized by that receptor. Novel hybrid genes like OR8U1
might allow novel odorants to be recognized. It is also in-
teresting to note that a subset of ORs could function out-
side the olfactory system, such as human OR1D2, which
appears to mediate sperm chemotaxis toward its ligand,
bourgeonal.58 The functional impact of OR-containing238 The American Journal of Human Genetics 83, 228–242, AugustCNVs could, therefore, extend to other phenotypes, in-
cluding male fertility. Like ORs, the red and green opsin
genes and a number of opsin pseudogenes are arranged
in a tandem cluster. Recent unequal-recombination events
and gene conversions between members of the opsin clus-
ter have resulted in duplications, deletions, and hybrid
genes segregating as human polymorphisms. Such events
result in altered color perception or color blindness,59 anal-
ogous to the altered chemosensory perception that we pre-
dict results from the OR copy-number variation we
describe here.
Phenotypic variation in olfactory ability has indeed been
observed in both human and mouse populations. Inability
to smell (anosmia), reduced olfactory sensitivity
(hyposmia), and enhanced abilities (hyperosmia) have all
been reported. Often, the detection of all odorants is af-
fected (generalized anosmia/hyposmia/hyperosmia),60,61
a phenomenon that is usually related to general health sta-
tus (e.g., respiratory infections, head injuries), alterations
in signal-transduction pathways, or developmental disor-
ders, such as Kallmann’s syndrome (KAL1 [MIM 308700],
KAL2 [MIM 147950], KAL3 [MIM 244200], KAL4 [MIM
610628]). Of greater interest in the context of our study
of variation in particular OR genes, speciﬁc anosmias, hy-
posmias, and hyperosmias that affect the ability to detect
only certain odorants have been described. Examples
include anosmia for musk (in some humans)62 and for iso-
valeric acid (in some mouse strains),63 as well as human
hyperosmia to asparagus metabolites64 and variation in
detection thresholds for isovaleric acid, androstenone,
and androstadienone (see below). Such phenotypic varia-
tion could be a direct consequence of the variation in
OR-repertoire size that we describe.
Two recent studies provided the ﬁrst links between var-
iation in speciﬁc OR genes and variation in human phe-
notypes. The inactive form of human OR11H7, caused
by a nonsense SNP, was shown to be signiﬁcantly less
prevalent in individuals hyperosmic for isovaleric acid
than in ‘‘normal’’ individuals.53 SNPs that change the
amino acid sequence of a second human OR, OR7D4,
were shown to affect detection thresholds and valence
(pleasantness) ratings for the testosterone-derived steroi-
dal odorants androstenone and androstadienone and
were shown to affect OR7D4’s ability to respond to those
odorants in in vitro functional assays.65 Interestingly, in-
dividuals who are heterozygous for OR7D4 variants have
phenotypes that are intermediate between the two classes
of homozygous individuals in terms of both odorant-de-
tection thresholds and valence,65 suggesting that changes
in the number of neurons that express particular receptor
types can alter olfactory abilities. By analogy, even though
individuals homozygous for OR deletions were relatively
rare in our study, the many individuals who are heterozy-
gous for OR copy-number changes might also possess an
altered sense of smell. Conversely, in some cases, the com-
binatorial nature of olfactory coding, in which multiple
receptors can recognize multiple odorants,8 might serve8, 2008
to reduce the impact of OR gene loss, given that other re-
ceptors might be partially or fully redundant with the lost
gene.
Elucidation of the functional consequences of the OR-
containing CNVs we have characterized will require
a great deal of additional work. To date, odorant ligands
have been identiﬁed for only a handful of human
ORs.53,58,65–69 Although some of these ORs are in candi-
date CNVRs according to whole-genome studies, none is
in the subset that we have conﬁrmed as truly copy-
number variable.
We have also shown that OR genes are statistically signif-
icantly enriched in CNVRs reported in whole-genome
studies. We argue that ORs (and V1Rs) are not enriched
in CNVRs as a result of positive selection and that enrich-
ment is more likely a result of a combination of (a) the
preponderance of these genes in segmentally duplicated
regions, which are known to be more susceptible to
copy-number variation than are unique regions of the ge-
nome,29,30 and (b) the fact that CNVs are depleted from
other genome regions that harbor dosage-sensitive genes.
Our ﬁndings apply to OR-containing CNVs as a class—it
is still possible that a small minority of OR-containing
CNVs are under positive selection. In contrast to neutrally
evolving OR-containing CNVs, other structural variants
appear to confer advantageous new functions70 or predis-
position to disease71 and are likely to be under signiﬁcant
selective pressures. A recent paper by Nozawa et al.39 (see
also comments by Zhang72) also suggested that OR-con-
taining CNVs accumulate neutrally, using arguments
based on the distribution of summed OR copy numbers
in the HapMap population.28 Our results are consistent
with Nozawa et al.’s ﬁndings, and we extend the argu-
ments favoring neutrality with our use of appropriate
statistical methods for measuring enrichment and our as-
sessment of the important contribution of segmental du-
plications to OR-CNVR enrichment. We also show that
whole-genome studies of CNVRs probably overestimate
the size of variable regions, in agreement with other recent
studies.47,51,52 Other known caveats of whole-genome
studies include their bias in favor of ﬁnding larger CNVs,
their tendency to bemore effective in identifying deletions
than in identifying duplications, the fact that some studies
avoided surveying regions of SDs whereas other studies
focused solely on those regions, and the fact that many
studies relied on the reference assembly for experimental
design and thus cannot survey sequences missing from
that assembly. These caveats highlight the need for addi-
tional genotyping and characterization of structurally var-
iant alleles at the sequence level,46 as we have done here
for a subset of OR-containing CNVs, before further conclu-
sions can be drawn about the phenotypic consequences of
variation in genes within putative CNVRs. Our conclusion
that OR CNVs are accumulating neutrally as a class is un-
likely to be affected by these caveats, because the issues
we describe are likely to affect intact ORs, OR pseudogenes,
and V1Rs approximately equally.The AmWe describe methods for assessing the statistical signiﬁ-
cance of the enrichment of ORs (or any other class of
genes) in a data set of genomic regions. Many other studies
have used hypergeometric tests that assume that each gene
has an independent chance of being in the regions of inter-
est, but these CNVR data sets contain larger regions that
can affect multiple related genes at once. The assumptions
of the test are therefore violated for gene families with
a clustered genomic arrangement, like the ORs, thus artiﬁ-
cially inﬂating p values by a ‘‘jackpot effect’’30. Use of sim-
ulations for the assessment of statistical signiﬁcance avoids
such problems and will be important for CNVR analyses,
like the one we describe here, as well as for functional anal-
yses of other data sets of large genomic regions; for exam-
ple, gene ontology (GO) analysis of regions lost or gained
in tumor samples.73
In summary, we show that at least 16 intact ORs are
variable in copy number in the human population.
These 16 copy-number-variable ORs, together with 26
SNPs that result in ‘‘segregating pseudogenes’’ (described
by other investigators13) and three more that were
revealed by this study, clearly show that huge variation
exists between humans in the number of functional
ORs that we possess and that this variation is likely to
underlie observed phenotypic variations in human
olfactory ability.
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Acknowledgments
We thank The Centre for Applied Genomics, University of Tor-
onto, for compiling the Database of Genomic Variants; Stefan
White for MLPA control probe sequences; and Stefan White
and MRC Holland for advice on MLPA protocols. We are also
grateful to Andy Siegel for statistical advice, to NIDCD for fund-
ing (DC0042090), to Fred Hutchinson Cancer Research Center’s
sequencing facility, to Mike Schlador for preparing some sam-
ples in our human DNA panel, to Christina Laukaitis and
Marco Salazar for comments on the manuscript, and to an
anonymous reviewer for helpful suggestions on our statistical
analyses.
Received: May 8, 2008
Revised: June 25, 2008
Accepted: July 7, 2008
Published online: July 31, 2008
Web Resources
The URLs for data presented herein are as follows:
Boxshade, http://www.ch.embnet.org/software/BOX_faq.html
Cross_match, http://www.phrap.org
HORDE, Human olfactory receptor data exploratorium, http://
bioportal.weizmann.ac.il/HORDE
MRC Holland, http://www.mlpa.comerican Journal of Human Genetics 83, 228–242, August 8, 2008 239
OMIM, Online Mendelian Inheritance in Man, http://www.ncbi.
nlm.nih.gov/Omim/
R, http://CRAN.R-project.org
RepeatMasker, http://www.repeatmasker.org
UCSC Genome Browser, http://genome.ucsc.edu
References
1. Buck, L., and Axel, R. (1991). A novel multigene family may
encode odorant receptors: a molecular basis for odor recogni-
tion. Cell 65, 175–187.
2. Glusman, G., Yanai, I., Rubin, I., and Lancet, D. (2001). The
complete human olfactory subgenome. Genome Res. 11,
685–702.
3. Niimura, Y., and Nei, M. (2007). Extensive gains and losses of
olfactory receptor genes in Mammalian evolution. PLoS ONE
2, e708.
4. Zhang, X., and Firestein, S. (2002). The olfactory receptor gene
superfamily of the mouse. Nat. Neurosci. 5, 124–133.
5. Young, J.M., Friedman, C., Williams, E.M., Ross, J.A., Tonnes-
Priddy, L., and Trask, B.J. (2002). Different evolutionary pro-
cesses shaped the mouse and human olfactory receptor gene
families. Hum. Mol. Genet. 11, 535–546.
6. Ngai, J., Chess, A., Dowling, M.M., Necles, N., Macagno, E.R.,
and Axel, R. (1993). Coding of olfactory information: topogra-
phy of odorant receptor expression in the catﬁsh olfactory
epithelium. Cell 72, 667–680.
7. Chess, A., Simon, I., Cedar, H., and Axel, R. (1994). Allelic in-
activation regulates olfactory receptor gene expression. Cell
78, 823–834.
8. Malnic, B., Hirono, J., Sato, T., and Buck, L.B. (1999). Combi-
natorial receptor codes for odors. Cell 96, 713–723.
9. Mombaerts, P., Wang, F., Dulac, C., Chao, S.K., Nemes, A.,
Mendelsohn,M., Edmondson, J., and Axel, R. (1996). Visualiz-
ing an olfactory sensory map. Cell 87, 675–686.
10. Gilad, Y., Man, O., and Glusman, G. (2005). A comparison of
the human and chimpanzee olfactory receptor gene reper-
toires. Genome Res. 15, 224–230.
11. Rat Genome Sequencing Project Consortium (2004). Genome
sequence of the Brown Norway rat yields insights into mam-
malian evolution. Nature 428, 493–521.
12. Quignon, P., Kirkness, E., Cadieu, E., Touleimat, N., Guyon, R.,
Renier, C., Hitte, C., Andre, C., Fraser, C., and Galibert, F.
(2003). Comparison of the canine and human olfactory re-
ceptor gene repertoires. Genome Biol. 4, R80.
13. Menashe, I., Man, O., Lancet, D., and Gilad, Y. (2003). Differ-
ent noses for different people. Nat. Genet. 34, 143–144.
14. Rouquier, S., Blancher, A., and Giorgi, D. (2000). The olfactory
receptor gene repertoire in primates and mouse: Evidence for
reduction of the functional fraction in primates. Proc. Natl.
Acad. Sci. USA 97, 2870–2874.
15. Gilad, Y., Man, O., Paabo, S., and Lancet, D. (2003). Human
speciﬁc loss of olfactory receptor genes. Proc. Natl. Acad. Sci.
USA 100, 3324–3327.
16. Gilad, Y., Przeworski, M., and Lancet, D. (2004). Loss of olfac-
tory receptor genes coincides with the acquisition of full tri-
chromatic vision in primates. PLoS Biol. 2, E5.
17. Bailey, J.A., Yavor, A.M., Massa, H.F., Trask, B.J., and Eichler,
E.E. (2001). Segmental duplications: organization and impact
within the current human genome project assembly. Genome
Res. 11, 1005–1017.240 The American Journal of Human Genetics 83, 228–242, August18. Trask, B.J., Friedman, C., Martin-Gallardo, A., Rowen, L., Akin-
bami, C., Blankenship, J., Collins, C., Giorgi, D., Iadonato, S.,
Johnson, F., et al. (1998). Members of the olfactory receptor
gene family are contained in large blocks of DNA duplicated
polymorphically near the ends of human chromosomes.
Hum. Mol. Genet. 7, 13–26.
19. Newman, T., and Trask, B.J. (2003). Complex evolution of 7E
olfactory receptor genes in segmental duplications. Genome
Res. 13, 781–793.
20. Quignon, P., Giraud, M., Rimbault, M., Lavigne, P., Tacher, S.,
Morin, E., Retout, E., Valin, A.S., Lindblad-Toh, K., Nicolas, J.,
et al. (2005). The dog and rat olfactory receptor repertoires.
Genome Biol. 6, R83.
21. Nei, M., Gu, X., and Sitnikova, T. (1997). Evolution by the
birth-and-death process in multigene families of the verte-
brate immune system. Proc. Natl. Acad. Sci. USA 94, 7799–
7806.
22. Li, W.H. (1997). Molecular evolution (Sunderland, MA: Sina-
uer Associates).
23. Linardopoulou, E., Mefford, H.C., Nguyen, O.T., Friedman, C.,
van den Engh, G., Farwell, D.G., Coltrera, M., and Trask, B.J.
(2001). Transcriptional activity of multiple copies of a subtelo-
merically located olfactory receptor gene that is polymorphic
in number and location. Hum. Mol. Genet. 10, 2373–2383.
24. Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lun-
din, P., Maner, S., Massa, H., Walker, M., Chi, M., et al.
(2004). Large-scale copy number polymorphism in the
human genome. Science 305, 525–528.
25. Tuzun, E., Sharp, A.J., Bailey, J.A., Kaul, R., Morrison, V.A.,
Pertz, L.M., Haugen, E., Hayden, H., Albertson, D., Pinkel,
D., et al. (2005). Fine-scale structural variation of the human
genome. Nat. Genet. 37, 727–732.
26. Conrad, D.F., Andrews, T.D., Carter, N.P., Hurles, M.E., and
Pritchard, J.K. (2006). A high-resolution survey of deletion
polymorphism in the human genome. Nat. Genet. 38, 75–81.
27. Nguyen, D.Q.,Webber, C., and Ponting, C.P. (2006). Bias of se-
lection on human copy-number variants. PLoS Genet. 2, e20.
28. Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., An-
drews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen,
W., et al. (2006). Global variation in copy number in the
human genome. Nature 444, 444–454.
29. Sharp, A.J., Locke, D.P., McGrath, S.D., Cheng, Z., Bailey, J.A.,
Vallente, R.U., Pertz, L.M., Clark, R.A., Schwartz, S., Segraves,
R., et al. (2005). Segmental duplications and copy-number var-
iation in the human genome. Am. J. Hum. Genet. 77, 78–88.
30. Cooper, G.M., Nickerson, D.A., and Eichler, E.E. (2007). Muta-
tional and selective effects on copy-number variants in the
human genome. Nat. Genet. 39, S22–S29.
31. Iafrate, A.J., Feuk, L., Rivera, M.N., Listewnik, M.L., Donahoe,
P.K., Qi, Y., Scherer, S.W., and Lee, C. (2004). Detection of
large-scale variation in the human genome. Nat. Genet. 36,
949–951.
32. Young, J.M., Kambere, M., Trask, B.J., and Lane, R.P. (2005).
Divergent V1R repertoires in ﬁve species: Ampliﬁcation in ro-
dents, decimation in primates, and a surprisingly small reper-
toire in dogs. Genome Res. 15, 231–240.
33. Walsh, S., Anderson,M., and Cartinhour, S.W. (1998). ACEDB:
a database for genome information. Methods Biochem. Anal.
39, 299–318.
34. Sonnhammer, E.L., and Durbin, R. (1995). A dot-matrix pro-
gram with dynamic threshold control suited for genomic
DNA and protein sequence analysis. Gene 167, GC1–GC10.8, 2008
35. Schwartz, S., Kent, W.J., Smit, A., Zhang, Z., Baertsch, R., Har-
dison, R.C., Haussler, D., andMiller,W. (2003). Human-mouse
alignments with BLASTZ. Genome Res. 13, 103–107.
36. Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang,
Z., Miller, W., and Lipman, D.J. (1997). Gapped BLAST and
PSI-BLAST: a new generation of protein database search pro-
grams. Nucleic Acids Res. 25, 3389–3402.
37. Thompson, J.D., Higgins, D.G., and Gibson, T.J. (1994). CLUS-
TAL W: improving the sensitivity of progressive multiple se-
quence alignment through sequence weighting, position-
speciﬁc gap penalties and weight matrix choice. Nucleic Acids
Res. 22, 4673–4680.
38. Schouten, J.P., McElgunn, C.J., Waaijer, R., Zwijnenburg, D.,
Diepvens, F., and Pals, G. (2002). Relative quantiﬁcation of
40 nucleic acid sequences by multiplex ligation-dependent
probe ampliﬁcation. Nucleic Acids Res. 30, e57.
39. Nozawa, M., Kawahara, Y., and Nei, M. (2007). Genomic drift
and copy number variation of sensory receptor genes in hu-
mans. Proc. Natl. Acad. Sci. USA 104, 20421–20426.
40. Falcon, S., and Gentleman, R. (2007). Using GOstats to test
gene lists for GO term association. Bioinformatics 23, 257–
258.
41. Liman, E.R. (2006). Use it or lose it: molecular evolution of
sensory signaling in primates. Pﬂugers Arch. 453, 125–131.
42. Khaja, R., Zhang, J., MacDonald, J.R., He, Y., Joseph-George,
A.M., Wei, J., Raﬁq, M.A., Qian, C., Shago, M., Pantano, L.,
et al. (2006). Genome assembly comparison identiﬁes struc-
tural variants in the human genome. Nat. Genet. 38, 1413–
1418.
43. International Human Genome Sequencing Consortium
(2004). Finishing the euchromatic sequence of the human
genome. Nature 431, 931–945.
44. Istrail, S., Sutton, G.G., Florea, L., Halpern, A.L., Mobarry,
C.M., Lippert, R., Walenz, B., Shatkay, H., Dew, I., Miller,
J.R., et al. (2004). Whole-genome shotgun assembly and com-
parison of human genome assemblies. Proc. Natl. Acad. Sci.
USA 101, 1916–1921.
45. Levy, S., Sutton, G., Ng, P.C., Feuk, L., Halpern, A.L., Walenz,
B.P., Axelrod, N., Huang, J., Kirkness, E.F., Denisov, G., et al.
(2007). The diploid genome sequence of an individual hu-
man. PLoS Biol. 5, e254.
46. Eichler, E.E., Nickerson, D.A., Altshuler, D., Bowcock, A.M.,
Brooks, L.D., Carter, N.P., Church, D.M., Felsenfeld, A., Guyer,
M., Lee, C., et al. (2007). Completing the map of human
genetic variation. Nature 447, 161–165.
47. Kidd, J.M., Cooper, G.M., Donahue, W.F., Hayden, H.S., Sam-
pas, N., Graves, T., Hansen, N., Teague, B., Alkan, C., Anto-
nacci, F., et al. (2008). Mapping and sequencing of structural
variation from eight human genomes. Nature 453, 56–64.
48. Bovee, D., Zhou, Y., Haugen, E., Wu, Z., Hayden, H.S., Gillett,
W., Tuzun, E., Cooper, G.M., Sampas, N., Phelps, K., et al.
(2008). Closing gaps in the human genome with fosmid re-
sources generated from multiple individuals. Nat. Genet. 40,
96–101.
49. Chimpanzee Sequencing and Analysis Consortium (2005).
Initial sequence of the chimpanzee genome and comparison
with the human genome. Nature 437, 69–87.
50. Gibbs, R.A., Rogers, J., Katze, M.G., Bumgarner, R., Weinstock,
G.M., Mardis, E.R., Remington, K.A., Strausberg, R.L., Venter,
J.C., Wilson, R.K., et al. (2007). Evolutionary and biomedical
insights from the rhesus macaque genome. Science 316,
222–234.The Ame51. Perry, G.H., Ben-Dor, A., Tsalenko, A., Sampas, N., Rodriguez-
Revenga, L., Tran, C.W., Scheffer, A., Steinfeld, I., Tsang, P., Ya-
mada, N.A., et al. (2008). The ﬁne-scale and complex architec-
ture of human copy-number variation. Am. J. Hum. Genet.
82, 685–695.
52. de Smith, A.J., Tsalenko, A., Sampas, N., Scheffer, A., Yamada,
N.A., Tsang, P., Ben-Dor, A., Yakhini, Z., Ellis, R.J., Bruhn, L.,
et al. (2007). Array CGH analysis of copy number variation
identiﬁes 1284 new genes variant in healthy white males: im-
plications for association studies of complex diseases. Hum.
Mol. Genet. 16, 2783–2794.
53. Menashe, I., Abaffy, T., Hasin, Y., Goshen, S., Yahalom, V.,
Luetje, C.W., and Lancet, D. (2007). Genetic elucidation of
human hyperosmia to isovaleric acid. PLoS Biol. 5, e284.
54. Jakobsson, M., Scholz, S.W., Scheet, P., Gibbs, J.R., VanLiere,
J.M., Fung, H.C., Szpiech, Z.A., Degnan, J.H., Wang, K., Guer-
reiro, R., et al. (2008). Genotype, haplotype and copy-number
variation in worldwide human populations. Nature 451,
998–1003.
55. Freeman, J.L., Perry, G.H., Feuk, L., Redon, R., McCarroll, S.A.,
Altshuler, D.M., Aburatani, H., Jones, K.W., Tyler-Smith, C.,
Hurles, M.E., et al. (2006). Copy number variation: new in-
sights in genome diversity. Genome Res. 16, 949–961.
56. Linardopoulou, E.V., Williams, E.M., Fan, Y., Friedman, C.,
Young, J.M., and Trask, B.J. (2005). Human subtelomeres are
hot spots of interchromosomal recombination and segmental
duplication. Nature 437, 94–100.
57. Korbel, J.O., Urban, A.E., Affourtit, J.P., Godwin, B., Grubert,
F., Simons, J.F., Kim, P.M., Palejev, D., Carriero, N.J., Du, L.,
et al. (2007). Paired-end mapping reveals extensive structural
variation in the human genome. Science 318, 420–426.
58. Spehr, M., Gisselmann, G., Poplawski, A., Riffell, J.A., Wetzel,
C.H., Zimmer, R.K., and Hatt, H. (2003). Identiﬁcation of a tes-
ticular odorant receptor mediating human sperm chemotaxis.
Science 299, 2054–2058.
59. Nathans, J. (1999). The evolution and physiology of human
color vision: insights from molecular genetic studies of visual
pigments. Neuron 24, 299–312.
60. Tsai, P.S., andGill, J.C. (2006).Mechanisms of disease: Insights
into X-linked and autosomal-dominant Kallmann syndrome.
Nat. Clin. Pract. Endocrinol. Metab. 2, 160–171.
61. Holbrook, E.H., and Leopold, D.A. (2006). An updated review
of clinical olfaction. Curr. Opin. Otolaryngol. Head Neck Surg.
14, 23–28.
62. Whissell-Buechy, D., and Amoore, J.E. (1973). Odour-
blindness to musk: simple recessive inheritance. Nature 242,
271–273.
63. Griff, I.C., and Reed, R.R. (1995). The genetic basis for
speciﬁc anosmia to isovaleric acid in the mouse. Cell 83,
407–414.
64. Lison, M., Blondheim, S.H., and Melmed, R.N. (1980). A poly-
morphism of the ability to smell urinary metabolites of aspar-
agus. BMJ 281, 1676–1678.
65. Keller, A., Zhuang, H., Chi, Q., Vosshall, L.B., and Matsunami,
H. (2007). Genetic variation in a human odorant receptor
alters odour perception. Nature 449, 468–472.
66. Wetzel, C.H., Oles, M., Wellerdieck, C., Kuczkowiak, M., Gis-
selmann, G., and Hatt, H. (1999). Speciﬁcity and sensitivity
of a human olfactory receptor functionally expressed in hu-
man embryonic kidney 293 cells and Xenopus Laevis oocytes.
J. Neurosci. 19, 7426–7433.rican Journal of Human Genetics 83, 228–242, August 8, 2008 241
67. Sanz, G., Schlegel, C., Pernollet, J.C., and Briand, L. (2005).
Comparison of odorant speciﬁcity of two human olfactory re-
ceptors from different phylogenetic classes and evidence for
antagonism. Chem. Senses 30, 69–80.
68. Neuhaus, E.M., Mashukova, A., Zhang, W., Barbour, J., and
Hatt, H. (2006). A Speciﬁc Heat Shock Protein Enhances
the Expression of Mammalian Olfactory Receptor Proteins.
Chem. Senses 31, 445–452.
69. Schmiedeberg, K., Shirokova, E., Weber, H.P., Schilling, B.,
Meyerhof, W., and Krautwurst, D. (2007). Structural determi-
nants of odorant recognition by the human olfactory recep-
tors OR1A1 and OR1A2. J. Struct. Biol. 159, 400–412.
70. Perry, G.H., Dominy, N.J., Claw, K.G., Lee, A.S., Fiegler, H.,
Redon, R., Werner, J., Villanea, F.A., Mountain, J.L., Misra,242 The American Journal of Human Genetics 83, 228–242, August 8R., et al. (2007). Diet and the evolution of human amylase
gene copy number variation. Nat. Genet. 39, 1256–1260.
71. Aitman, T.J., Dong, R., Vyse, T.J., Norsworthy, P.J., Johnson,
M.D., Smith, J., Mangion, J., Roberton-Lowe, C., Marshall,
A.J., Petretto, E., et al. (2006). Copy number polymorphism
in Fcgr3 predisposes to glomerulonephritis in rats and
humans. Nature 439, 851–855.
72. Zhang, J. (2007). The drifting human genome. Proc. Natl.
Acad. Sci. USA 104, 20147–20148.
73. Holcomb, I., Grove, D., Kinnunen,M., Friedman, C., Gallaher,
I., Morgan, T., Sather, C., Delrow, J., Nelson, P., Lange, P., et al.
(2008). Genomic alterations indicate tumor origin and varied
metastatic potential of disseminated cells from prostate-
cancer patients. Cancer Res. 68, 5599–5608., 2008
